PCM
CPXX

Pentwater Capital Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Pentwater Capital Management’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-315,400
Closed -$9.52M – 145
2016
Q2 		$9.52M Buy
+315,400
New +$6.4M 0.13% 59

Pentwater Capital Management's CPXX Position: Q3 2016 in Review

Pentwater Capital Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 315,400 shares — an estimated $9.52M sold.

Pentwater Capital Management first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $9.52M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Pentwater Capital Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Pentwater Capital Management sold 315,400 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $9.52M.
  • Pentwater Capital Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Pentwater Capital Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $9.52M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Pentwater Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.